Abstract:Objective To evaluate the association between serum 25-hydroxyvitamin D (25 [OH] D) levels and the clinical severity in cerebral infarction patients, and to explore the inlfuence in prognosis of those patients who received 25 (OH) D treatment. <br> Methods Serum concentrations of 25 (OH) D were measured among 217 patients who developed acute cerebral infarction and 163 health control subjects who were free of stroke. These patients were divided into different groups based on the serum 25 (OH) D concentrations for analyzing the proportion of each group in patients with cerebral infarction and compared with healthy control group. The difference about clinical data and their correlation were evaluated among the cerebral infarction patients with different 25 (OH) D levels. All of the patients with the serum 25 (OH) D<20 ng/ml were divided into two subgroups according to whether received vitamin D therapy and compared in 1 year follow-up for indicators such as serum 25 (OH) D levels, recurrence rates of the endpoint events and average modiifed Rankin Scale scores. <br> Results The serum 25 (OH) D concentrations were signiifcantly decreased in the cerebral infarction patients compared with the healthy control group, the mean value was (13.67±1.16) ng/ml and (20.11±2.05) ng/ml, respectively (P=0.001). In the cerebral infarction group, the prevalence of 25 (OH) D deficiency and sufficiency, showed obvious differences compared with the healthy control group. Compared to the serum 25 (OH) D≥20 ng/ml, the serum 25 (OH) D<20 ng/ml was more often in the cerebral infarction patients with hypertension, diabetes and coronary heart disease (P=0.010, P=0.011, P=0.037). There was a negative correlation between serum 25 (OH) D level and admission National Institutes of Health Stroke Scale (NIHSS) score in patients (r=-0.720, P=0.001). Among all of the cerebral infarction patients with serum 25 (OH) D levels<20 ng/ml, the subgroup which received vitamin D treatment had a recurrence rate of transient ischemic attack (TIA) or cerebral infarction and an average modiifed Rankin Scale score within one year, both were lower than that not received vitamin D treatment, but showing no statistically signiifcant differences (P=0.080, P=0.079). <br> Conclusion The lower serum 25 (OH) D levels in the patients with cerebral infarction were associated with the severity, but the evidence was still lacking that vitamin D treatment would reduce the occurrence of risk of ischemic stroke and improve patient prognosis.

Serum levels of 25-OH vitamin D levels predict cognitive impairments among acute coronary syndrome patients

The study on the relationship between the levels of serum CysC and cognitive function in patients with acute cerebral lacunar infarction

Low Serum Superoxide Dismutase is Associated with a High Risk of Cognitive Impairment after Mild Acute Ischemic Stroke

Serum 25-Hydroxyvitamin D in Relation to Disability in Activities of Daily Living, Mobility, and Objective Physical Functioning among Chinese Older Adults.

Lower 25-Hydroxyvitamin D is Associated with Severer White Matter Hyperintensity and Cognitive Function in Patients with Non-Disabling Ischemic Cerebrovascular Events.

Change and clinical value of serum 25-hydroxyvitamin D level in elderly patients with mild cognitive impairment

Serum Uric Acid and High-Sensitivity C-Reactive Protein As Predictors of Cognitive Impairment in Patients with Cerebral Infarction

Serum 25-hydroxyvitamin D deficiency predicts poor outcome amongst acute ischaemic stroke patients with low high density lipoprotein cholesterol.

Clinical Study on Relationship of Serum 25-Hydroxyvitamin D and Cerebral Infarction and the Interventional Treatment

Serum Cortisol is Associated with Cerebral Small Vessel Disease-Related Brain Changes and Cognitive Impairment

Serum 25-hydroxyvitamin D deficiency predicts poor outcome among acute ischemic stroke patients without hypertension.

Association between serum 25-hydroxyvitamin D3 level and cognitive impairment in older chronic kidney disease patients

Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke

Serum 25(OH)D and β2 microglobulin levels in elderly patients with diabetes mellitus complicated with cognitive dysfunction and their clinical significance

Serum Vitamin D3 Concentration, Sleep, and Cognitive Impairment among Older Adults in China

The Correlation Between Serum 25 Vitamin D Level and Acute Coronary Syndrome

Serum Vitamin D as a Marker of Impaired Information Processing Speed and Early Disability in Multiple Sclerosis Patients

Decreasing Serum 25-Hydroxyvitamin D Levels and Risk of Early Neurological Deterioration in Patients with Ischemic Stroke.

Advances in Serological Biomarkers and Imaging to Predict Post-Stroke Cognitive Impairment

Relationship between serum 25-hydroxyvitamin D level and post-stroke depression in the elderly with acute stroke

Depressed Serum 25-Hydroxyvitamin D Levels Increase Hospital Stay and Alter Glucose Homeostasis in First-ever Ischemic Stroke